Facilitated By

San Antonio Medical Foundation

ANALYTICAL AND PK ANALYSES OF DE-IDENTIFIED PATIENT SAMPLES FROM THE CLINICAL PHASE IB/II TRIAL OF L-NMMA PLUS DOCETAXEL IN THE TREATMENT OF REFRACTORY LOCALLY ADVANCED OR METASTATIC TRIPLE NEGATIVE BREAST CANCER PATIENTS

UT Health San Antonio

The UT Health San Antonio, with missions of teaching, research and healing, is one of the country’s leading health sciences universities.

Principal Investigator(s)
Kuhn, John G
Funded by
HOUSTON METHODIST RESEARCH INSTITUTE
Research Start Date
Status
Active
Collaborative Project
Clinical Care
Cancer